Europe
For its 2019 list of the top 50 most innovative companies, Fast Company selected 10 from the biotech industry that are having a significant impact on the treatment of patients. The first five are highlighted.
ASIT biotech, a Belgian biopharmaceutical company specialized in the research and development of innovative allergy immunotherapy products, announces its preliminary financial calendar for 2019.
Simon Moroney, CEO and co-founder of MorphoSys AG informed the Company’s Supervisory Board that he has decided not to renew his contract as a member of the company’s Management Board.
Planegg/Munich, Germany, February 19, 2019 Simon Moroney, CEO and co-founder of MorphoSys AG, informed the Company’s Supervisory Board that he has decided not to renew his contract as a member of the company’s Management Board.
Medtronic plc, the global leader in medical technology, announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration for its Personalized Closed Loop insulin pump system, currently in development.
Medtronic plc announced financial results for its third quarter of fiscal year 2019, which ended January 25, 2019.
ADL Bionatur Solutions, by partnering with Nutricion Center NC, opens up big opportunities in the Spanish pharmacy sector: reaching over 2,000 direct sales points; and 20,000 pharmacies
The Lead Discovery Center is part of a new consortium of eight partners from industry and academia focusing on the development of new diabetes therapies.
On Tuesday, Novo Nordisk said the FDA approved its Biologics License Application for Esperoct (turoctocog alfa pegol) formerly known as N8-GP, for the treatment of children and adults with hemophilia A.
Shares of France-based Inventiva have plunged more than 45 percent after the company reported that its experimental treatment for a rare autoimmune disease failed to hit primary and secondary endpoints in a mid-stage trial.
PRESS RELEASES